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Abstract: The leading causes of mortality and morbidity worldwide are cardiovascular 
disease (high blood pressure, high cholesterol and renal disease), cancer and diabetes. It is 
increasingly obvious that the development of these diseases encompasses complex interactions 
between adult lifestyle and genetic predisposition. Maternal malnutrition can influence the 
fetal and early life environment and pose a risk factor for the future development of adult 
diseases, most likely due to impaired organogenesis in the developing offspring. This then 
predisposes these offspring to cardiovascular disease and renal dysfunction in adulthood. Studies 
in experimental animals have further illustrated the significant impact maternal diet has on 
offspring health. Many studies report changes in kidney structure (a reduction in the number 
of nephrons in the kidney) in offspring of protein-deprived dams. Although the early studies 
suggested that increased blood pressure was also present in offspring of protein-restricted 
dams, this is not a universal finding and requires clarification. Importantly, to date, the literature 
offers little to no understanding of when in development these changes in kidney development 
occur, nor are the cellular and molecular mechanisms that drive these changes well characterised. 
Moreover, the mechanisms linking maternal nutrition and a suboptimal renal phenotype in 
offspring are yet to be discerned—one potential mechanism involves epigenetics. This review 
will focus on recent information on potential mechanisms by which maternal nutrition  
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(focusing on malnutrition due to protein restriction, micronutrient restriction and excessive 
fat intake) influences kidney development and thereby function in later life. 
Keywords: developmental programming; kidney development; maternal diet 
 
1. Maternal Nutrition and the Kidney 
A plethora of evidence exists for to support the crucial role that the environment plays during 
development in determining the future health of the offspring. Developmental programming refers to the 
mechanism underlying this phenomenon and is defined as “a permanent change in the structure or 
function of an organism due to alterations in development that occur in response to an environmental 
stimulus during critical periods of organ development” [1]. Particularly implicated is maternal nutrition, 
which has been shown to have an effect on offspring health, with both over- and under-nutrition having 
negative consequences on offspring health [2–5]. A number of studies have provided evidence to support the 
hypothesis that maternal nutritional status plays a critical role on the health and wellbeing of the fetus [6–8]. 
Changes to maternal nutritional status may change the ability of the mother to supply the growing fetus 
with the required nutrients for optimal growth. Initial studies during early and mid 20th Century documented 
the nutritional requirements during pregnancy in humans [9,10] as well as animals [11–14], indicating 
the importance of a diet containing sufficient amounts of essential nutrients (proteins, fats, carbohydrates) 
and micronutrients (iron and calcium) and a sufficient caloric value. These studies reported that protein 
or micronutrient restriction in the mother lead to poor offspring growth in utero and in early postnatal 
life. It was much later that we began to appreciate the biological consequences of these fetal trade-offs 
in response to a sub-optimal maternal diet. 
Perturbations to the maternal diet during pregnancy and/or lactation are associated with increased  
risk of renal, cardiovascular and metabolic disease in the offspring [15,16]. The developing kidney is 
particularly susceptible to the effects of a suboptimal maternal diet; changes in expression of genes and 
proteins important for kidney development, are likely to underlie the developmental programming of 
kidney structure and physiology. This paper will review the literature to describe the role of maternal 
macro- and micro-nutrient imbalance in influencing fetal and neonatal kidney development, final nephron 
complement and the effect of these structural abnormalities on adult function. The mechanisms underlying 
these observations will also be discussed. 
In order to understand developmental programming of renal structure and function in humans, animal 
models using dietary interventions have been established. This is primarily due to the difficulty in quantifying 
structure of the human kidney by non-invasive methods. For example, the effects of maternal dietary 
zinc, vitamin A and protein restriction or maternal dietary fat excess all have been shown to have a 
negative impact on kidney development and later renal disease in the offspring [16–19]. Furthermore, a 
decrease in nephron number is hypothesized to lead to disrupted fluid and electrolyte balance, which in 
turn, may lead to volume expansion and finally glomerular hyperfiltration and systemic hypertension [20]. 
Importantly, restricted maternal protein intake in pregnancy has been linked to reduced birth weight, impaired 
nephron endowment, elevated blood pressure and reduced glomerular filtration rate (GFR) [21–29].  
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1.1. Maternal Protein Restriction Programs Reduced Nephron Number but the Physiological 
Consequences are Unclear 
Interestingly, despite there being a consistent observation from several research groups that protein 
restriction during development results in a reduction in nephron number, the follow-on effects on renal 
function (characterized by a measurement of glomerular filtration rate; GFR) and blood pressure are far 
from clear due to inconsistent techniques used. For example, early studies by Woods et al. [26] clearly 
showed that male offspring from protein restricted dams had a 25% nephron deficit, an 11% GFR 
reduction and a 10 mmHg increase in mean arterial blood pressure compared with control rats. The 
calculated single nephron glomerular filtration rate in these protein deprived offspring was 20% greater in 
protein-restricted than in protein-replete controls [26]. Increases in individual nephron GFR can be an 
indication of renal hyperfiltration, which can ultimately lead to further nephron loss, perpetuating this 
cycle [20]. 
Later studies demonstrated that the phenotype induced by maternal protein-deprivation is not invariant. 
Woods et al. [27] reported that maternal diet affected offspring in a sex-specific manner; female offspring 
of protein restricted Sprague-Dawley rats did not demonstrate hypertension or a nephron deficit. This 
suggests that sex-dependent variations in developmental programming of the kidney exist, are subtle and 
highly reliant on the concentration of dietary protein or, potentially, timing of the intervention. 
Furthermore, reductions in nephron endowment associated with intrauterine protein restriction, are not 
always accompanied by hypertension. For example, Zimanyi et al. (2006) reported a nephron deficit in 
Wistar-Kyoto (WKY) rats fed an 8.7% (low) protein diet (control rats were fed a 20% protein diet) with 
no alteration in blood pressure or evidence of renal hyperfiltration in the protein-restricted group [30]. 
Maternal low-protein or caloric restricted diets induce low birth weight in the offspring [31,32] and this 
reduction in body size may correlate with changes in cardiovascular function and growth [33,34].  
Catch-up growth may exacerbate the adverse consequences, such as hypertension, of developmental 
programming [15,35,36]. Together, these data suggest that maternal protein restriction during pregnancy 
most likely results in altered kidney and morphology but the follow-on effects on physiology and function 
are currently not well understood. The variability in phenotype may be resultant from exposure to dietary 
insult at different points of kidney development. Knowledge of the molecular processes involved in 
controlling kidney development and ultimately adult morphology are essential for understanding the 
impact of maternal protein restriction and will be discussed in further detail later in the review. 
1.2. Maternal Overnutrition Has Subtle Impacts upon Kidney Development and Function in  
the Offspring 
Although early programming studies focused on the role of maternal undernutrition as models for the 
Dutch Hunger Winter studies [37–39], it is apparent that overnutrition is now a major risk to human 
health and wellbeing. The concept of maternal malnutrition must therefore be expanded to include excess 
caloric or fatty acid intake [40–44]. Over nutrition and obesity during pregnancy is risk factor for poor 
outcomes for offspring health, including the susceptibility to chronic diseases [45,46] as well as mortality 
from these diseases [42,47]. Investigating neonatal outcomes in obese mothers, Catalano et al. [48] 
report that maternal obesity leads to fetuses with greater fat mass, and insulin resistance. Likewise, 
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Boney et al. [49] reported that children born large-for-gestational-age to obese mothers were at a greater 
risk of developing metabolic syndrome. In a rabbit model of maternal high-fat feeding (containing 13% 
fat), Prior et al. [50] report greater mean arterial pressure (6 mmHg), heart rate (13 bpm) and renal 
sympathetic nerve activity (1.3 nU) compared with controls. These animals were slightly heavier 
throughout postnatal life and at 4 months of age had significantly heavier white adipose tissue (64%) 
compared with controls. Similarly, Jackson and colleagues report glomerular sclerosis and reduced 
kidney function (increased urine albumin excretion) in offspring exposed to a maternal diet high in 
fructose and fat compared to controls [51]. In a rat model of maternal high fat feeding, Armitage et al. 
(2005) report no change in nephron endowment in offspring of fat fed dams compared with controls, but 
these same high fat offspring had abnormal renal renin activity which the authors hypothesized to 
underlie the increased mean arterial pressure [52]. 
The mechanism by which maternal over nutrition leads to poor health outcomes is not fully understood. 
Obesity is linked to a chronic inflammatory state in both the mother and fetus [53] and it is possible that 
this is mediating the changes in gene expression and the development of the offspring.  
1.3. Maternal Micronutrient Status and Its Impact on Offspring Kidney Health 
In utero development is characterized by rapid cell synthesis and therefore the developing fetus has 
a particularly high demand for nutritional substrate. Micronutrients are critical co-factors in enzymatic 
pathways of cell synthesis in the fetus and therefore there is a high dietary demand for these compounds 
during pregnancy. Maternal deficiencies in micronutrients can have lasting detrimental effects on the 
fetus and again there is evidence that the kidney is preferentially affected. Lelievre-Pegorier et al. [54] 
report a 20% reduction in nephron number in adult rats born to mothers that were fed a vitamin A 
deficient diet during 3 weeks prior to pregnancy, throughout pregnancy up until day 21 of gestation. The 
mechanism underlying this abnormal kidney phenotype is most likely the fact the vitamin A is a key 
ligand for the cRET receptor, which controls the earliest processes of kidney development (see Section 2 for 
full details).  
Although the role of vitamin A is well established, other maternal micronutrient deficiencies are 
associated with abnormal kidney structure or function in her offspring; but with less clear mechanisms 
Lisle et al. [55] reported that diet-induced maternal iron deficiency is associated with greater systolic 
blood pressure and reduced glomerular number in adult offspring, when compared with controls. Similarly 
in a model of maternal zinc restriction, Tomat and colleagues [17,56,57] reported reduced nephron number 
and kidney function (determined by nitric oxide synthase activity) as well as greater blood pressure (tail 
cuff plethysmography) when compared with controls. The pathway by which different micronutrient 
deficiency leads to similar morphological phenotypes remains unknown; zinc deficiency has negative 
effects on branching morphogenesis; a process key to kidney development, but can also impact upon the 
development of the placenta, thereby affecting the growth potential of the entire embryo or fetus [58]. 
Given the great disparity in the forms of maternal dietary challenge it is intriguing that a similar 
phenotype is observed in the offspring in response to challenges as diverse as zinc or protein deficiency. 
This prompts the hypothesis that fundamental processes in kidney development may be sensitive to an 
array of abnormal signals from the environment, eliciting a common adaptive response and resulting in 
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a characteristic phenotype. In order to discuss these mechanisms, we will first consider the factors that 
underpin the development of the kidney. 
2. Kidney Development 
2.1. Early Signaling: Specification of the Ureteric Bud and Metanephric Mesenchyme 
The kidneys play a vital role in health and disease. In mammals, the kidney develops through three 
successive stages (Figure 1): 
The Pronephros, a rudimentary structure that develops from the lateral plate and intermediate 
mesoderm and continues to develop into the mesonephros [59].  
The Mesonephros, a transient organ, although the mesonephric (nephric) duct is important for the 
development of the metanephros, the permanent mammalian kidney [59]. 
The Metanephros which begins to develop at day 35 in human gestation, embryonic day 11.5 (E11.5) 
in the mouse [60] and embryonic day E12–E13 in rats [61,62]. 
 
Figure 1. Kidney development. The mammalian kidney develops through three stages 
(pronephros, mesonephros and metanephros). The pronephros develops from the nephric duct, 
following which, mesonephric development occurs in conjunction with the degeneration of 
the pronephros and the formation of the mesonephric tubules. The metanephros develops 
from the induction of the metanepheric mesenchyme by the ureteric bud from the nephric 
(Wolffian) duct. As the ureteric bud branches into the metanephric mesenchyme, the 
mesenchyme around the tips of this branching structure are induced to form renal vesicles. 
Renal vesicles will progress through the comma-shaped body and S-shaped body stages before 
connecting to the collecting system of the developing kidney to form a developed nephron. 
Nephrogenesis is complete by 36 weeks gestation in humans, by about PN3 (postnatal) in mice [59,63] 
and PN7 in rats [64]. The metanephros begins to develop when cells from the caudal end grow out from 
the Wolffian duct (or mesonephric duct) forming the ureteric bud in response to growth factors (discussed in 
the following sections) secreted by the metanephric mesenchyme [59,64–66]. Under the influence of 
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these growth factors, the ureteric bud invades the metanephric mesenchyme and branches forming the 
collecting duct system.  
2.2. Genetic Control of Kidney Development 
2.2.1. Control of Branching: Molecules Involved in Branching and Inhibiting Lateral Branching 
Branching morphogenesis is the dichotomous arborisation of ureteric epithelium and is responsible 
for the development of the collecting duct system of the kidney. The process of branching morphogenesis 
is tightly regulated by inhibitors (BMP4, bone morphogenic protein 4), promoters (GDNF, glial derived 
neurotrophic factor and c-RET, c-ret tyrosine kinase receptor) and growth factors (TGF, transforming 
growth factor β superfamily). These genes are essential regulators of ureteric bud branching and 
patterning [67] (Figure 2). 
 
Figure 2. Molecular control of early kidney development. Early development of the 
metanephros, the permanent mammalian kidney, is under tight molecular control. Outgrowth 
and branching morphogenesis of the ureteric bud is controlled by the expression of receptors 
Gfrα1 and C-ret to which Gdnf binds. Production of Gdnf is under the influence of Pax2, 
Together these factors stimulate branching morphogenesis of the kidney. Bmp4 inhibits lateral 
branching of the ureteric, which ensures tight control of branching morphogenesis. Induction 
of the metanephric mesenchyme to undergo epithelial to mesenchymal transition is influenced 
by Wnt4 and Hnf4α. The formation of renal vesicles (from the cap mesenchyme) is controlled 
by the number of Six2 positive cells (denoting renal stem cells). Once committed to forming 
a nephron, these cells begin to express Pax2, Wnt4 and Hnf4α. 
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Branching morphogenesis begins with the interaction between the metanephric mesenchyme and  
the ureteric bud, whereby inductive signals from both embryonic derivatives (GDNF is released from 
the metanephric mesenchyme and binds to its receptors c-RET and GFRα1 at the tips of the ureteric bud) 
initiate the branching process [68–72]. Tight regulation of branching morphogenesis is essential to both 
kidney development and function.  
2.2.2. Control of Nephrogenesis: Epithelial-Mesenchymal Transition (EMT) 
Nephrogenesis is intricately involved with branching morphogenesis. The induction of nephron 
development occurs only at the tips of the developing ureteric tree. Metanephric mesenchymal cells adjacent 
to the ureteric branch tips are induced, leading to condensation, epithelialization and proliferation of the 
cap mesenchyme. This induced mesenchyme expresses genes involved in extracellular matrix formation 
and remodeling, cell-adhesion molecules, cell survival and proliferation [73–75]. Under influence of the 
genes Pax2, Wnt4 and Hnf4α [76–79] the induced mesenchyme undergoes epithelialisation and differentiates 
successively into renal vesicles, comma-shaped bodies, S-shaped bodies before the glomerular vascular 
tuft develops and attaches to the proximal tubule to finally form mature nephrons, the functional units 
of the kidney. 
3. Specification of Nephron Structures 
The induced mesenchyme continues to develop through various morphological steps including a 
comma-shaped body which is characterised by expression of the primitive podocyte marker MNFB and 
genes involved with Bmp signalling including Bmp2, 4, 7 [80–84]. Then, the comma-shaped body develops 
into an S-shaped body through FGF8 and PAX2 signalling [77,85,86], linking up with the ureteric 
epithelium. The S-shaped body contains the primitive cells of the glomerulus with the invasion of angiogenic 
cells. With capillarisation and connecting to the tubule (influenced by FGF2 and LIF expression) [87] 
the basic structure of the nephron is complete. However, the nephron continues to undergo maturation 
in the form of tubular elongation.  
The metanephric mesenchyme is preserved through the maintenance of a population of progenitor 
cells. This leads to sufficient support of the progression and development of nephrogenesis. Extensive 
study, aimed at identifying the genes involved in the maintenance of this cell population, has indicated 
the importance of Six2, Fgf2 and Bmp7 [88,89]. Self et al. [90] reported that knockout of Six2 lead to 
premature development of renal vesicles. This suggests that Six2 is required to maintain a population of 
cells required for the development of progenitor cells that form renal vesicles. The generation of Six2 
positive cells is related to cortical stromal cells expressing Foxd1, which suggests that there are complex 
interrelationships between cell subsets that give rise to cells that can control the development of 
structures within the kidney [91]. 
4. Arcade Formation 
In humans nephrogenesis is complete by approximately 36 weeks of gestation, while in rodents, 
nephrogenesis continues for a short time after birth [64,92]. Until approximately 14–15 weeks of pregnancy 
in humans, and the end of gestation in rodents, each tip of the ureteric tip connects to a single nephron 
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produced by the surrounding mesenchyme. When arborisation of the ureteric tree is finished and branching 
ceases, nephrogenesis continues by a process of nephron arcade formation whereby multiple nephrons 
attached to the same tip.  
A second nephron is induced by the same tip, attaches to this tip and the connecting tubule of the 
older nephron shifts to the new nephron. Other nephrons are then induced until four to seven nephrons 
form an arcade arrangement by being attached to the stalk rather than just to the tips forming a common 
connecting segment. Arcade formation enables deep and mid-cortical nephrons to connect to collecting 
ducts located in the renal cortex [93]. After 20–22 weeks of gestation in humans, and by the very end of 
kidney development in rodent, nephrons are attached individually and directly along the entire length of 
the collecting duct and are not incorporated in the arcade [63,65]. Arcade formation is thought to be 
underpinned by the activity of a number of genes within the Notch pathway as they are involved in the 
formation of intercellular connections (such as N-cadherin and integrins), however further elucidation 
of the mechanism is required [94]. Arcade formation is a period of rapid nephron formation and therefore 
disruption of kidney development durign this critical window can have a profound impact.  
5. Final Nephron Endowment 
The processes controlling the time at which nephrogenesis ends are less well described than  
those controlling active nephrogenesis. One hypothesis is that the population of cells in the metanephric 
mesenchyme limits the magnitude of cells that can aggregate and differentiate into nephrons. Indeed this 
has been proposed as a factor underlying the large variability in nephron number in mammals [95–97]. 
In human, the peak period of nephrogenesis occurs during the last third of pregnancy after the cessation 
of branching morphogenesis. The progenitor cells of the metanephric mesenchyme provide the basis 
from which all the cells of the nephron will differentiate. For this reason, as the population of metanephric 
mesenchyme diminishes there is a natural cessation of nephrogenesis. 
Nephron endowment is also dependent upon the branching capacity of the ureteric bud, as nephrons 
only form adjacent to ureteric tips [54,64,98]. Retarded branching of the ureteric epithelium can therefore 
manifest in a permanent reduction of nephrons and impaired kidney growth. 
In addition, factors involved in the ureteric branching and the epithelisation of the metanephric 
mesenchyme including growth factors and their receptors, degrading enzyme, proto-oncogenes, 
transcription factors, suppressor genes extracellular matrix, teratogens and fetal/maternal environment 
are all involved in the regulation of kidney development and can impinge on nephron endowment [61,99]. 
It is perhaps not surprising therefore that the number of nephrons in human kidneys varies widely, from 
300,000 to nearly 2 million [95,100–106]. 
Early Investigations Supporting Changes during Kidney Development (Genes and Pathways, Cells  
and Timing) 
Kidney development occurs across a number of periods of plasticity and is therefore subject to a 
number of “critical periods” when external insults may produce life-long structural and potentially functional 
changes in kidney. Importantly, once kidney development is complete (at around gestational week 38 in 
humans and postnatal day 8 in rat), no further nephrons are formed. Therefore, a reduction in nephron 
number caused by interventions during kidney development persists throughout life and may contribute 
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to the burden of disease in later life. Singh et al., 2007 showed in rats that glucocorticoid exposure during 
the early stages of kidney development (embryonic day E14 to E15), permanently decreased nephron 
number at PN30 [98]. This is in agreement with an earlier study by Woods et al. (2004), which showed 
that maternal protein restriction during the second half of the pregnancy, when nephrogenesis is active, 
is associated with a reduction in nephron endowment [28].  
Interestingly, the dietary insult need not occur during the period of active nephrogenesis to promote 
a reduction in nephron number. Welham et al. 2005 demonstrate that exposure low protein maternal diet 
from start of the pregnancy until day E13 in rats (prior to the onset of nephrogenesis) is sufficient to cause 
reduction in glomerular numbers by approximately 20% [99]. Additionally, uteroplacental insufficiency 
and reduction in litter number has similar effect during the late stage kidney development [107,108]. 
Conversely, removing dietary insult during postnatal life may improve glomerular numbers [107,109] 
owing to the fact that nephrogenesis in rats proceeds until approximately PN7-8. These studies together 
suggest that dietary insults during critical developmental window may cause changes, especially, in kidney 
morphology, which may translate to physiological deficits. 
The underlying nephron deficit observed in studies of maternal dietary manipulation must be 
underpinned by changes in the expression of genes and proteins. However, only few studies have analyzed 
the early gene expression profiles of the kidney exposed to a suboptimal intrauterine environment and 
how these changes lead to nephron deficit still remains unclear. Abdel-Hakkem and colleagues (2008) 
induced global caloric restriction in Sprague-Dawley rats, and analyzed 10 critical genes involved in 
branching morphogenesis and nephrogenesis at E20 [110]. Genes involved in mesenchymal to epithelial 
transformation (Wnt4, Wt1, Fgf2 and Bmp7) were found to be up-regulated, while genes involved in 
branching morphogenesis (Pax2, Gdnf, Fgf7, Bmp4, and Wnt11) were down-regulated [110]. Additionally, 
proteins of GDNF and MAPK-ERK pathway (e.g., Gfraα1, phosphorylated ERK1/2 and mitogen-activated 
protein kinase 1/2) are altered already at E20 by maternal food restriction, indicating the importance of these 
pathways for normal nephrogenesis [111]. In addition a recent study in rats, adult offspring (16 weeks) 
of low-protein dams showed up-regulation of TGF-β1 and ZEB2 mRNA in kidneys displaying nephron 
deficit [112]. The authors further suggested that TGF-β1 may induce ZEB2 expression further leading 
to down-regulation of specific miRNAs within the glomeruli, leading to altered function [112]. These studies 
suggest that aberrant gene expression of various pathways may underlie reduced nephron endowment, 
however, the exact mechanism remain to be determined. 
For some time, there have been suggestions that apoptosis of mesenchymal cells in developing 
kidneys play a role in the reduction of nephron endowment [113]. Rats exposed to a maternal LP diet 
demonstrated a 20% reduction in adult nephron number and up-regulation of apoptotic pathways (e.g., 
Bax and Bcl-2) [99]. Apoptotic gene expression is also altered by maternal undernourishment [114] 
particularly increased levels of proteins in late embryonic life (E20; Fas-receptor and Caspase-9) and 
early postnatal life (PN1; Fas-receptor and caspase-3). These molecular changes were accompanied with 
increased apoptosis in the nephrogenic zone (the area of active nephrogenesis) of the kidney [115]. These 
findings demonstrated that maternal programming might increase apoptosis in the developing kidney, 
which in turn may contribute to nephron deficit.  
Other mechanisms proposed to contribute to the nephron deficit, include dysregulation of the  
Renin-angiotensin system (RAS). Angiotensin is essential in forming blood vessels and tubules during 
nephrogenesis as well as the development of smooth muscle in the ureter [116,117]. Thus, deficits in 
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nephron number may be preceded by suppression of RAS further contributing to disturbed fluid and 
electrolyte balance (dysfunction of kidney) and adulthood hypertension. Interestingly, a recent report 
suggests sex-specific alteration of RAS system is induced by in utero exposure to a low-protein diet [19]. 
Cooke et al. 2014 showed that expression of Angiotensin converting enzyme (ACE) was up-regulated 
in male, but not in female offspring, as early as at E19 relative to control [19]. Additionally, expression 
of the G-protein coupled receptor of RAS, AT1R, was observed in male offspring at PN21 [19]. Thus, 
maternal low protein diet may alter nephron numbers in the developing kidney through altered expression of 
the RAS system, especially in the male offspring. Another study has highlighted the potential function 
of the Na co-transporters and the RAS in the developmental programming of the kidney [109]. Na-K-Cl 
co-transporter and Na-Cl co-transporters display functional role in Na reabsorption in kidney and altering 
levels of these co-transporter could ultimately lead to development of adulthood hypertension.  
The exact mechanism underpinning the programming of a nephron deficit remains unknown, but most 
likely involve alterations in multiple pathways such as apoptotic-pathways, RAS and specific EMT 
related pathways. The mechanism underlying these gene modulations is proposed to be heritable but not 
related to mutations in the genome. 
6. Maternal Diet and the Offspring Epigenome 
Changed gene expression; not mutations within the genome, but changes in the way that the genome 
is expressed, is controlled by epigenetic “marks” such as gene methylation, histone modifications and 
the binding of DNA proteins. These marks can act independently or in concert to modify expression  
of genes. Epigenetics may play a role in developmental programming of adult disease as it provides a 
mechanism that explains the change in gene expression, and therefore the change in phenotype. These 
changes can be brought about through multiple epigenetic pathways. 
The maternal environment, before, during and after birth can have a significant impact on the 
epigenome of the offspring [118–122]. Essentially, the epigenetic profile of the organism is malleable 
during any stage of development—as during this stage the genome is undergoing modifications and 
specification. Before the genome becomes heritably stable, changes in the epigenetic profile can be 
incorporated into the phenotypic profile and therefore be inherited over multiple cellular cycles and alter 
the gene expression of that cell line or organ system. One of the most well studied models of how the maternal 
environment affects the offspring genome through epigenetic mechanisms, is that of the agouti mouse. 
The agouti viable yellow (AvY) mouse strain has been used extensively to demonstrate the effects of 
a methyl deficient diet and subsequent disease outcome. The agouti gene is under the control of a methylation 
sensitive promoter and infers a yellow coat colour and an increased preponderance to obesity, diabetes, 
cancer and a shorter lifespan when expressed [123–125]. Pregnant AvY mice exposed to methyl deficient 
diets give birth to pups displaying variable coat colours but the majority of offspring present with the agouti 
phenotype. This phenotype occurs in response to hypomethylation of the agouti locus and an increase in 
expression. The phenotype is not reversible by later methyl donor supplementation. Where methyl donors 
are freely available in the maternal diet, the agouti locus remains methylated and the gene repressed, 
thus the majority of offspring have a brown coat and normal physiology, metabolism and life expectancy. 
Studies that have investigated the consequences of maternal dietary manipulation on offspring 
phenotype, commonly report changes in gene expression and major function in the offspring [126]. 
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Epigenetic control of gene expression is maintained and regulated by three major mechanisms: DNA 
methylation, histone acetylation and non-protein coding RNA [126]. Few studies have investigated the 
role of epigenetics in kidney development however there is strong evidence that relatively high level 
(i.e., changes to enzymes that have wide-reaching effects, rather than those that control a particular 
process of kidney development) epigenetic changes may drive later kidney disease. Pham et al. [127] used 
uteroplacental insufficiency as a model of intrauterine growth restriction and report that CpG methylation of 
p53 was altered leading to changes in expression of genes involved in apoptosis within the kidney. While 
methylation is one form of epigenetic modification, there is also the production and implication of 
microRNAs. The importance of Dicer; the enzyme which cleaves non-coding microRNAs into active 
microRNAs during mammalian kidney development has been shown by Nagalakshmi et al. [128]. These 
authors used a transgenic mouse model (Six2Cre) where Dicer was conditionally ablated from the 
progenitors of the nephron epithelium. The removal of Dicer lead to elevated apoptosis and premature 
termination of nephrogenesis. Ablation of Dicer from ureteric bud epithelium (using HoxB7Cre transgenic 
mice) resulted in disrupted branching morphogenesis and the development of renal cysts [128]. Likewise 
in a mouse model with the conditional knockout of Dicer1 from the developing urogenital tract,  
Pastorelli et al. [129] report renal abnormalities including hydronephrosis and cyst formation. Furthermore, 
offspring had increased renal apoptosis combined with reduced glomerular number. These results 
illustrate the importance of miRNA function during kidney development.  
Offspring of rats whose mothers were fed protein restricted diets in pregnancy and lactation 
demonstrate global changes to the methylation status of whole organs, and important gene pathways that 
play a major role in kidney development and adult function [130–132]. These studies have further 
investigated these effects to show that important enzymes involved in setting the methylation profile of 
the genome are altered (specifically DNMT1, which is involved in maintaining the methylation status of 
the genome during replication), as well as receptors involved in protein metabolism [133,134]. Given 
that methylation is highly dependent on dietary intake of methyl donors, it has now been demonstrated 
that when either the maternal or early postnatal diet are supplemented with methyl donors (such as glycine 
and folic acid), the deleterious cardiovascular effects of maternal protein restriction may be at least 
partially ameliorated or rescued. Song et al. 2010, suggest that a number of genes underlying ureteric 
bud formation (including elements of the renin angiotensin system) are controlled by histone acetylation; 
certainly HDAC inhibitors have a negative impact on kidney development. Interestingly, despite the intense 
interest in determining epigenetic changes in models of maternal or developmental programming, there 
is still little direct evidence for an epigenetic modification in the development of kidney disease or 
morphological abnormality [135]. This is likely due to the complex interplay between histone acetylation, 
gene methylation and miRNA post-translational modifications.  
7. The Impact of Nephron Endowment on Adult Cardiovascular and Renal Health 
As nephrons are the functional units of the kidney a reduction in number is theoretically detrimental 
to kidney function. Low nephron number may result in adult kidney dysfunction including hypervolaemia, 
electrolyte balance and toxaemia [136] and is implicated in hypertension and renal disease [137].  
The mechanism underlying this link between nephron number and cardiovascular/renal function  
was first described and popularized by Brenner et al. [20]. Brenner hypothesised that a reduction in renal 
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filtration surface area (due to either lower nephron number or lower filtration surface area per 
glomerulus) would lead to limited sodium excretion, secondary hypervolaemia which promotes an increase 
in glomerular capillary pressure. Over time this excessive pressure results in glomerular sclerosis [20], 
further reductions filtration surface area a further increase in systemic blood pressure.  
There is strong evidence to support the hypothesis that there is an associate between nephron number 
and blood pressure but due to fact that present methods for estimating human nephron endowment can only 
be conducted post mortem it is not possible to show causation. Keller et al. [105] reported an inverse 
association between nephron endowment and hypertension in humans. However, it was unclear whether 
the lower numbers of nephrons in subjects with a history of hypertension were responsible for hypertension 
or a consequence of hypertension. Keller et al. [105] analysed kidneys obtained at autopsy from Caucasian 
subjects (normotensive and hypertensive patients) between the age of 35 and 59 years, and found that 
10 normotensive subjects had a median glomerular number of 1,429,200 while 10 hypertensive subjects 
had a median glomerular number of 702,379. Although it was unclear whether the lower numbers of 
nephrons in subjects with a history of hypertension were responsible for hypertension or a consequence 
of hypertension. The hypertensive patients showed very few obsolescent glomeruli which may suggest 
that the hypertension had not caused the deficit in nephron number. Douglas-Denton et al. [100] also 
reported that hypertensive subjects have significantly fewer nephrons (746,468 ± 133,240) than 
normotensive subjects (1,402,360 ± 346,357). 
Low birth weight (LBW) is often used as an indication of intra-uterine growth restriction and has 
been correlated with the incidence of kidney disease [138,139]. For example, Lackland [138] provided 
evidence that kidney failure and end-stage renal disease demonstrate a racial and geographic disparity. 
This concept is supported by findings of Hoy et al. [101] that the kidneys of Australian Aboriginals 
contain 30% fewer nephrons than those of non-indigenous Australians. This phenomenon may explain 
in part why Australian Aborigines in remote areas have a much greater incidence of renal disease (as 
well as hypertension and cardiovascular disease) than non-Aboriginal peoples in remote areas [140].  
A study by Lackland [141] focused on the incidence of hypertension, demonstrating that adults born with 
LBW had a much higher systolic blood pressure and were more likely to suffer from hypertensive-related 
end-stage renal disease than those of normal birth weight. Investigating the developing kidney in the 
human fetus, Lori et al. [142] report that IUGR was associated with reduced renal volume compared to 
gestational-age adjusted controls. While renal volume can be indicative of nephron number, no technique is 
available for in situ measurement of human fetal nephron number. The investigation by Lori et al. does 
provide information on how the human intrauterine environment impacts directly upon the kidney and 
the finding is repeatable. A more recent investigation by Wang et al. [143] in human fetal kidneys also 
reports that fetal growth restriction is associated with smaller kidneys which appears to be caused by 
increased apoptosis and reduced expression of renin and angiotensinogen. 
Although the limited human data appear to be supportive of an association between low birth weight 
and reduced kidney size this association is not always observed in animal studies [144] where tighter 
control over experimental conditions and potential bias are possible. In support of this hypothesis 
Langley-Evans et al. [145] reported that a deficit of 13% in nephron number was associated with a  
13 mmHg elevation in arterial pressure of protein-restricted offspring (Wistar rats exposed to a 9% protein 
diet, while controls had a normal 18% protein diet). On the other hand, no relationship between nephron 
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number and blood pressure was found in female offspring from protein restricted Sprague-Dawley dams 
(on a 8.5% protein diet, while controls were on a 19% protein diet) by Woods et al. [27]. 
Investigations into the relationship between nephron number and cardiovascular health do not support 
the Brenner Hypothesis unconditionally (see review by Kett and Denton [146]. Nephron deficiency is 
not always associated with elevated arterial pressure. For example, Zimanyi et al. (2006) reported a 
nephron deficit in offspring of WKY rats fed an 8.7% (low) protein diet (while control rats were fed a 
20% protein diet) but blood pressure and renal filtration were normal [30]. The absence of change in 
blood pressure between the dietary groups may also be a product of offspring exposed to maternal protein 
restriction failing to demonstrate catch-up growth.  
Moreover, reduced nephron endowment does not necessarily underlie systemic high blood pressure, 
in a model of hypertension unrelated to maternal nutrition. Investigating the Spontaneously Hypertensive 
Rat (SHR), Black and colleagues [147] report no change in nephron number but a 29 mmHg increase in 
blood pressure (measured via tail cuff plethysmography). This is in contrast to the findings of  
Skov et al. [148] who reported reduced nephron number in the SHR compared to normotensive WKY 
rats. While it is understood that the hypertension that develops in the SHR is multifactorial, the relationship 
that nephron endowment may play is unclear. The results from these studies indicate that the relationship 
between nephron number and blood pressure is not direct and may be influenced by other factors 
including the renin-angiotensin-aldosterone systems and aberrant sympathetic nerve activity. The other 
potential confounding factor is the blood pressure measurement technique. Tail-cuff plethysmography 
is known to induce a stress response in animals that may lead to increased blood pressure [149,150]. 
Further studies are required using less stressful techniques, such as radiotelemetry [149,150], to further 
elucidate the underlying mechanism of hypertension within the SHR. 
Tonkiss and colleagues, using radiotelemetry devices, reported that malnourished rat offspring  
(6% maternal LP diet) demonstrated a 4 mmHg increase in diastolic blood pressure compared with 
controls, however offspring of protein-restricted rats elicited a greater cardiovascular arousal response 
(increased systolic pressure) to acute stress compared with controls [151]. This same study did not report 
nephron number in malnourished offspring, but did find that malnourished offspring weighed the same 
as controls at the time of blood pressure measurement. In a rat model of maternal caloric restriction, 
Brennan and colleagues reported a nephron deficit and no change in adult blood pressure (recorded using 
radiotelemetry) [152]. Lim et al. [153] report that in rats exposed to maternal protein restriction that 
while there was no change in mean arterial pressure (consciously measured with indwelling catheters) 
there was greater filtration of the kidney. Therefore, the question still remains about the relative contribution 
of postnatal growth and nephron number to adult blood pressure. 
Although multiple studies have reported low nephron number in offspring of dams exposed to a 
protein-restricted diet, the renal physiological effects of this reduction in nephron number have received 
less attention and findings have been contradictory. Alwasel and Ashton [154] reported no change in 
GFR in male or female rat offspring exposed to maternal LP diet (no nephron number reported), while 
Nwagwu et al. [23] reported reduced GFR in rat offspring exposed to maternal LP diet (no nephron 
number reported). Hoppe et al. [22] using a model of life long protein restriction in rats reported no 
change in GFR with a 31% reduction in nephron number. 
Sidduque et al. (2014) show no association between hypertension and low nephron number in the 
offspring of Sprague Dawley rats fed 6% protein from 12 days of gestation [109]. Neonates of these 
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dams were cross-fostered and studied. Offspring exposed to a high protein diet (20% w/w) in utero and 
cross-fostered to a mother fed a low-protein (6% protein) diet showed increased blood pressure and 
expression of the co-transporters after birth relative to control animals (20% protein throughout  
life) [109]. Surprisingly, these animal maintained similar nephron number and blood pressure compared 
with controls [109]. On the other hand, animals that were maintained on a protein restricted diet 
throughout the pregnancy and suckling recorded increased blood pressure, increased expression of renin 
and ANGII, had reduced nephron number, but did not show alteration in the Na co-transporter expression 
relative to controls [109]. This study indicates that dietary impact at different time points indeed could 
affect kidney development through different pathways. In summary, suboptimal maternal diet may alter 
gene and protein expression in the developing kidney leading to permanent reduction of nephron number 
but whether or not this results in hypertension is clearly dependent on other, yet to be identified factors.  
There is also evidence that pre- vs. post-natal nutritional planes have differing effects on kidney 
development in altricial species such as rats and mice. Jennings and colleagues used a cross-fostering 
method in rats to compare the contributions of the fetal and postnatal environments on offspring  
growth [155]. Pups that were exposed to protein restriction in utero then switched to a control dam post 
birth underwent catch-up growth and had similar weight to control pups by PN21, while pups that were 
maintained on a low protein diet postnatally did not. In fact, pups that underwent catch-up growth had 
reduced longevity. Investigations into catch-up growth also report changes in insulin sensitivity [156] 
and reduced β-cell proliferation and islet size during fetal life [157]. Wlodek et al. [107] using an 
uteroplacental insufficiency model in rats to induce fetal growth restriction report that offspring that 
were growth restricted in utero and postnatally had higher blood pressure as well as a nephron deficit, 
compared to controls. Meanwhile, offspring that were restricted in utero and were then cross-fostered to 
control dams did not have a reduced nephron endowment or increased blood pressure [107]. These 
studies indicate that postnatal nutrition of offspring is critical to the development of disease. Many 
studies that have linked maternal low protein diet to reduced nephron endowment and hypertension also 
observed accelerated growth postnatally [26,158,159]. 
The difficulty in translating these rodent studies back to the human condition is that rats and mice  
are born immature and nephrogenesis proceeds for up to a week postnatal. In humans, this process of 
nephrogenesis occurs in utero until 38 weeks gestation, therefore the postnatal period has little impact 
upon term infants. In the premature infant, however, the situation may be very different because these 
children are born whilst nephrogenesis is ongoing. Moreover, in many cases, the supply of breast milk 
is constrained in mothers of premature infants and formula supplementation may be required.  
Investigating the impact of preterm birth in humans on kidney development and function, Gubhaju et al. 
2014 report that renal function was affected by gestational age and may be linked to renal maturity [160]. 
Assessing the maturity of preterm kidneys, Sutherland et al. (2011) report that while there is a renal 
maturation in infants born preterm (before the cessation of nephrogenesis) this accelerated maturation is 
associated with morphologically small glomeruli [161]. These data further illustrate that in both animals 
and humans there is great potential for the kidney to be influenced by the environment, whether that be 
maternal or postnatal.  
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8. Conclusions 
The dietary intake and nutritional status of pregnant and breastfeeding mothers is a major public 
health concern given the robust evidence from human and animal studies which indicates that a healthy 
pregnancy (normal birth weight and absence of congenital defects) predicts a healthy start to life that 
will continue into the offspring’s adult life. Indeed, maternal malnutrition is still a major health concern 
world-wide, in both developing nations (malnutrition) and developed nations (over-nutrition). The 
consequence of poor maternal diets can potentially affect future generations, leading to them developing 
hypertension, diabetes, obesity or the metabolic syndrome. Of particular interest is the susceptibility of 
the kidney to the in utero environment because this organ develops slowly and across most of fetal life. 
The molecular control of the kidney has been well-reported (www.gudmap.org), however the impact of 
maternal diet on these molecular targets not been. It remains to be discovered when the maternal diet 
influences kidney development, what molecular processes are effected and if the phenotype can be rescued 
or halted. While the current generation’s in utero experience cannot be altered, there are protective 
measures that can be encouraged to minimise the potential for the in utero environment to be deleterious 
to future health.  
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